bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
3.540
-0.460 (-11.50%)
At close: Mar 30, 2026, 4:00 PM EDT
3.520
-0.020 (-0.56%)
Pre-market: Mar 31, 2026, 6:38 AM EDT
bioAffinity Technologies Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for bioAffinity Technologies in the last 12 months.
Price Target: n/a
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for bioAffinity Technologies is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 1, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $180 | Strong Buy | Initiates | $180 | +4,984.75% | Jul 23, 2024 |
Financial Forecast
Revenue This Year
7.45M
from 6.16M
Increased by 20.95%
Revenue Next Year
n/a
from 7.45M
EPS This Year
-8.26
from -8.66
EPS Next Year
n/a
from -8.26
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 |
|---|---|
| High | 7.7M |
| Avg | 7.5M |
| Low | 7.2M |
Revenue Growth
| Revenue Growth | 2026 |
|---|---|
| High | 24.5% |
| Avg | 21.0% |
| Low | 16.2% |
EPS Forecast
| EPS | 2026 |
|---|---|
| High | -8.51 |
| Avg | -8.26 |
| Low | -7.94 |
EPS Growth
| EPS Growth | 2026 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.